Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry.
Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.
Closing Bell brings you all the latest business, tech, political, and market news.
HBO's "Happening: A Clean Energy Revolution" is one of the few documentaries that's actually hopeful about the environment. Filmmaker James Redford joins us to discuss what went into making his latest project.
VF Hive looks at the intersection of Wall Street, Silicon Valley and Washington D.C. and the egos that drive them. Between Bells follows the latest business, technology, and culture news.
When you think of volcanoes in the United States, Hawaii likely comes to mind. However, America's most dangerous volcano isn't on an island.
Actress Fran Drescher speaks on her Cancer Schamancer movement. She recommends avoiding GMOs, choosing organics, and checking labels for responsible manufacturing.
In "The Martian," astronaut Mark Watney is able to grow potatoes on Mars with a combination of Martian soil and fecal matter. "Mythbusters" co-hosts Jon Lung and Brian Louden want to know if that's really possible.
Co-hosts Jon Lung and Brian Loudon dish on the new season, which makes its move to the Science Channel. Here's a look at some of this season's myths that are just dying to be busted.
